Amgen receives FDA approval for chronic heart failure medicine Corlanor

Amgen receives FDA approval for chronic heart failure medicine Corlanor
Amgen has received approval from the US Food and Drug Administration (FDA) for its Corlanor (ivabradine) to treat patients with chronic heart failure.

read at http://www.pharmaceutical-technology.com/news/newsamgen-receives-fda-approval-chronic-heart-failure-medicine-corlanor-4555383?WT.mc_id=DN_News

View On WordPress